BIO-Europe Spring 2013 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

BIO-Europe Spring 2013


BIO-Europe Spring® 2013 — 7th International Partnering Conference
Where the global biotech industry comes to partner

Location:
Barcelona, Spain

Date:
March 11–13, 2013

Venue:
CCIB Convention Centre Barcelona

Venue address:
CCIB Convention Centre
Rambla Prim 1–17
08019 Barcelona
Spain

Venue website:
www.ccib.es

Event Website:
www.ebdgroup.com/bes

The seventh annual BIO-Europe Spring® conference is the premier springtime partnering conference for the biotechnology industry. For its 2013 edition, BIO-Europe Spring comes to Barcelona, Spain on March 11–13, 2013.

The conference annually attracts the international “who’s who” from biotech, pharma and finance for three days of high caliber networking. BIO-Europe Spring’s world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business. Attend BIO-Europe Spring and take advantage of the opportunity for more partnering meetings in the three days of the conference than in the rest of the year.

Based on attendance at previous events, BIO-Europe Spring 2013 will bring together more than 2,200 executives from biotechnology, pharmaceutical and finance companies from around the world, who will engage in some 12,000 partnering meetings.

Partnering at BIO-Europe Spring is powered by partneringONE®, the leading conference solution for helping life science delegates meet efficiently and effectively. partneringONE has the unique ability to manage the complex interactions among thousands of executives from many different companies.

This sophisticated web-based partnering system enables delegates to screen potential partners, pre-arrange meetings and manage the entire conference partnering process.

Delegates can log in and connect with the conference community, anytime, anywhere.

Producer:
EBD Group AG

Supported by:
Biotechnology Industry Organization (BIO)

Contacts:
In the USA
Christina Hundschell
2032 Corte del Nogal, Suite 120
Carlsbad, CA 92011, USA
T: +1 760 930 0500
F: +1 760 030 0520
chundschell@ebdgroup.com

In Europe
Manuela Hildebrand
Isartorplatz 4
80331 Munich
Germany
T: +49 89 23 88 756 0
F: +49 89 23 88 756 55
mhildebrand@ebdgroup.com

Intended for:
Executives from:

  • Established and emerging biotech and medtech companies
  • Pharmaceutical companies
  • Institutional financial firms
  • Private investors including venture capital and private equity firms
  • Other industry related service companies

Speakers:
Please see website

Cost:
Please see website: http://www.ebdgroup.com/bes/registration

Program:
Please see website: http://www.ebdgroup.com/bes/program/index.php

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
22%
To all process for new products only
12%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search

Click here